Apoptosis induced by 2-chloro-adenosine and 2-chloro-2'-deoxy-adenosine in a human astrocytoma cell line: Differential mechanisms and possible clinical relevance

Journal of Neuroscience Research

Volumn 60, Issue 3, 2000, Pages 388-400

  Ceruti, Stefania ^a   Franceschi, Claudio ^c,d   Barbieri, Daniela ^c   Malorni, Walter ^e   Camurri, Alessandra ^a   Giammarioli, Anna Maria ^e   Ambrosini, Anna ^a   Racagni, Giorgio ^a,b   Cattabeni, Flaminio ^a   Abbracchio, Maria P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d INRCA   (Italy)

^e ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

2 CA; Apoptosis; Astrocytoma; Cell cycle; Cladribine

Indexed keywords

2 CHLOROADENOSINE; CLADRIBINE;

APOPTOSIS; ARTICLE; ASTROCYTOMA CELL; CELL DEATH; CELL VIABILITY; CYTOTOXICITY; DERIVATIZATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MACROGLIA; MEMBRANE TRANSPORT; NEUROTRANSMITTER RELEASE; PRIORITY JOURNAL; RECEPTOR BINDING;

2-CHLOROADENOSINE; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; ASTROCYTOMA; BRAIN NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL LINE; CELL NUCLEUS; CELLS, CULTURED; CEREBRAL CORTEX; CLADRIBINE; COLORING AGENTS; CULTURE MEDIA; FLOW CYTOMETRY; HUMANS; MICE; TETRAZOLIUM SALTS; THIAZOLES; TUMOR CELLS, CULTURED;

EID: 0034193432     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000501)60:3<388::AID-JNR14>3.0.CO;2-V     Document Type: Article

References (38)

1. Abbracchio MP. 1996. P1 and P2 receptors in cell growth and differentiation. Drug Dev Res 39:393-406.
2. Abbracchio MP, Ceruti S, Barbieri D, Franceschi C, Malorni W, Biondo L, Burnstock G, Cattabeni F. 1995. A novel action for adenosine: apoptosis of astroglial cells in rat brain primary cultures. Biochem Biophys Res Commun 213:908-915.
3. 3 receptor. Ann NY Acad Sci 825:11-22.
4. Abbracchio MP, Saffrey MJ, Hopker V, Burnstock G. 1994. Modulation of astroglial cell proliferation by analogues of adenosine and ATP in primary cultures of rat striatum. Neuroscience 59:67-76.
5. Ambrosini A, Bresciani L, Fracchia S, Brunello N, Racagni G. 1995. Metabotropic glutamate receptors negatively coupled to adenylate cyclase inhibit N-methyl-D-aspartate receptor activity and prevent neurotoxicity in mesencephalic neurons in vitro. Mol Pharmacol 47:1057-1064.
6. Ambrosini A, Tininini S, Barassi A, Racagni G, Sturani E, Zippel R. 2000. cAMP cascade leads to Ras activation in cortical neurons. Mol Brain Res 72262: 54-60.
7. Arner ESJ, Eriksson S. 1995. Mammalian deoxyribonucleoside kinases. Pharm Ther 67:155-186.
8. Barry MA, Behnke CA, Eastman A. 1990. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40:2353-2362.
9. Beutler E. 1992. Cladribine (2-chlorodeoxyadenosine). Lancet 340:952-956.
10. Bryson HM, Sorkin EM. 1993. Cladribine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in hematological malignancies. Drugs 46:872-894.
11. Carson DA, Wasson DR, Beutler E. 1984. Antileukemic and immunosuppressive activity of 2-chloro-2′ deoxyadenosine. Proc Natl Acad Sci USA 81:2232-2236.
12. Ceruti S, Barbieri D, Veronese E, Cattabeni F, Cossarizza A, Giammarioli AM, Malorni W, Franceschi C, Abbracchio MP. 1997. Different pathways of apoptosis revealed by 2-chloro-adenosine and deoxy-D-ribose in mammalian astroglial cells. J Neurosci Res 47:372-383.
13. Cheson BD. 1995. Infectious and immunosuppressive complications of purine analog therapy. J Clin Oncol 13:2431-2448.
14. Colombel M, Olsson CA, Ng PY, Buttyan R. 1992. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle. Cancer Res 52:4313-4319.
15. Dolbeare F, Gratzner H, Pallavicini M, Gray JW. 1983. Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proc Natl Acad Sci USA 8:5573-5577.
16. Dunwiddie TV, Abbracchio MP, Bischofberger N, Brundege JM, Buell G, Collo G, Corsi C, Diao L, Kawashima E, Jacobson KA, Latini S, Lin RCS, North RA, Pazzagli M, Pedata F, Pepeu GC, Proctor WR, Rassendren F, Surprenant A, Cattabeni F. 1996. Purinoceptors in the central nervous system. Drug Dev Res 39:361-370.
17. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M 1994. Nomenclature and classifications of purinoceptors. Pharm Rev 46:143-156.
18. Gao X, Knudsen TB, Ibrahim MM, Haldar S. 1995. Bcl-2 relieves deoxyadenylate stress and suppresses apoptosis in pre-B leukemia cells. Cell Death Differ 2:69-78.
19. Geiger JD, Parkinson F, Kowaluk E. 1997. Regulators of endogenous adenosine levels as therapeutic agents. In: Jacobson KA, Jarvis M, editors. Purinergic approaches in experimental therapeutics. Neu York: Wiley-Liss, Inc. p 55-84.
20. 3 receptors: novel ligands and paradoxical effects. Trends Pharmacol Sci 19:184-191.
21. Jacobson KA, Hoffmann C, Cattabeni F, Abbracchio MP. 1999. Adenosine-induced cell death: evidence for receptor-mediated signaling. Apoptosis 4:197-211.
22. Jarvis SM, Martin BW, Ng AS. 1985. 2-Chloroadenosine, a permeant for the nucleoside transporter. Biochem Pharmacol 34:3237-3241.
23. King KL, Cidlowski JA. 1995. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochem 58:175-180.
24. Kleihues P, Soylemezoglu F, Schauble B, Scheithauer BW, Burger PC. 1995. Histopathology, classification and grading of gliomas. Glia 15:211-221.
25. Liliemark J. 1997. The clinical pharmacokinetics of cladribine. Clin Pharmacokinet 32:120-131.
26. Malomi W, Rainaldi G, Rivabene R, Santini MT. 1994. Different susceptibilities to cell death induced by l-butylhydroperoxide could depend upon cell histotype-associated growth features. Cell Biol Toxicol 10:207-218.
27. O'Neill CF, Ormerod MG, Robertson D, Titley JC. 1996. Apoptotic and non-apoptotic cell death induced by cis and trans analogues of a novel ammine(cyclohexylamine) dhydroxodichloroplatinum (IV) complex. Br J Cancer 74:1037-1045.
28. Pardridge WM, Yoshikawa T, Kang Y-S, Miller LP. 1993. Blood-brain barrier transport and brain metabolism of adenosine and adenosine analogs. J Pharm Exp Ther 268:14-18.
29. Petit P, Loubatieres-Mariani MM, Keppens S, Shechan MJ. 1996. Purinergic receptors and metabolic function. Drug Dev Res 39:413-425.
30. Plunkett W, Saunders PP. 1991. Metabolism and action of purine nucleoside analogs. Pharm Ther 49:239-268.
31. 2) receptor selective agonists. Int J Immunopharmacol 17:221-224.
32. Sorenson CM, Barry MA, Eastman A. 1990. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cis platin. J Natl Cancer Inst 82:749-755.
33. Tallmann MS, Hakimian D. 1995. Purine nucleoside analogs: emerging roles in indolent lymphoproliferative disorders. Blood 86:2463-2474.
34. 2 receptors, adenosine inhibits the production of tumor necrosis factor-α of endotoxin-stimulated human polymorphonuclear leukocytes. J Lab Clin Med 126:275-282.
35. Ullman B, Gudas L, Cohen A, Martin D. 1978. Deoxyadenosine metabolism and cytotoxicity in cultured mouse T lymphoma cells: a model for immunodeficiency disease. Cell 14:365-375.
36. 3H]-SCH 58261 binding. Br J Pharmacol 122:355-375.
37. 3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59-67.
38. Wood AJJ. 1994. New purines analogues for the treatment of hairy cell leukemia. N Engl J Med 330:691-697.